SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Diabetes Prevention 
Access and Care Act’’. 
TITLE I—NATIONAL INSTITUTES 
OF HEALTH 
SEC. 101. RESEARCH, TREATMENT, AND EDUCATION. 
(a) IN GENERAL.—Subpart 3 of part C of title IV 
of the Public Health Service Act (42 U.S.C. 285c et seq.) 
is amended by adding at the end the following section: 
‘‘SEC. 434B. DIABETES IN MINORITY POPULATIONS. 
‘‘(a) IN GENERAL.—The Director of NIH shall ex-
pand, intensify, conduct, coordinate, and support research 
and other activities with respect to pre-diabetes and diabe-
tes, particularly type 2, in minority populations, including 
research to identify clinical, socioeconomic, geographical, 
cultural, and organizational factors that contribute to type 
2 diabetes in such populations. 
‘‘(b) CERTAIN ACTIVITIES.—Activities under sub-
section (a) regarding type 2 diabetes in minority popu-
lations shall include the following: 
‘‘(1) Research on behavior and obesity, includ-
ing research through the obesity research center that 
is sponsored by the National Institutes of Health. 
‘‘(2) Research on environmental factors that 
may contribute to the increase in type 2 diabetes, 
which shall be conducted or supported through the 
VerDate Aug 31 2005 
18:12 Apr 30, 2006
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5225.IH
H5225
jlentini on PROD1PC65 with BILLS
National Institute of Environmental Health Sciences 
and the National Human Genome Research Insti-
tute. 
‘‘(3) Support for new methods to identify envi-
ronmental triggers and genetic interactions that lead 
to the development of type 1 and type 2 diabetes in 
minority newborns with a high genetic susceptibility 
to the disease. Such research should follow the 
newborns through puberty, which is a high-risk pe-
riod for developing type 1 diabetes, and—increas-
ingly—type 2 diabetes. 
‘‘(4) Research to identify genes that predispose 
individuals to the onset of developing type 1 and 
type 2 diabetes and to develop complications. 
‘‘(5) Research to prevent complications in indi-
viduals who have already developed diabetes, such as 
attempting to identify the genes that predispose in-
dividuals with diabetes to the development of com-
plications, as well as methods and alternative thera-
pies to control blood glucose. 
‘‘(6) The support of ongoing research efforts 
examining the level of glycemia at which adverse 
outcomes develop during pregnancy and to address 
the many clinical issues associated with minority 
VerDate Aug 31 2005 
18:12 Apr 30, 2006
Jkt 049200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5225.IH
H5225
jlentini on PROD1PC65 with BILLS
mothers and fetuses during diabetic and gestational 
diabetic pregnancies. 
‘‘(c) TREATMENT.— 
‘‘(1) IN GENERAL.—The Director of NIH shall 
conduct and support programs to treat diabetes in 
minority populations. 
‘‘(2) CERTAIN
ACTIVITIES.—Activities under 
paragraph (1) regarding the treatment of diabetes in 
minority populations shall include recommending 
and disseminating, through the National Center on 
Minority Health and Health Disparities, the guide-
lines of the American Diabetes Association for nutri-
tion exercise and diet for diabetes treatment and 
prevention. 
‘‘(d) EDUCATION.—The Director of NIH shall— 
‘‘(1) through the National Center on Minority 
Health and Health Disparities— 
‘‘(A) make grants to programs funded 
under section 485F (relating to centers of ex-
cellence) for the purpose of establishing a men-
toring program for health care professionals to 
be more involved in weight counseling, obesity 
research, and nutrition; and 
VerDate Aug 31 2005 
18:12 Apr 30, 2006
Jkt 049200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5225.IH
H5225
jlentini on PROD1PC65 with BILLS